Mode
Text Size
Log in / Sign up

Clinical Trial Search

Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.

Phase
Intervention
Population
Results posted

65,437 trials

Phase 3 N=185 Safety and Tolerability of Conversion From Oral, Injectable, or Infusion Disease Modifying Therapies to Dose-titrated Oral Siponimod (Mayzent) in Advancing RMS Patients

Multiple Sclerosis · Relapsing Multiple Sclerosis · Advancing Multiple Sclerosis
Primary: Number of Participants With at Least One Treatment-emergent Adverse Event (TEAE) Related to Study Drug During the Treatment Period — 59 Participants
Novartis Pharmaceuticals Results Jul 2023 4.9% serious AE View details

Phase 4 N=40 Inpatient Penicillin Allergy Delabeling Study

Penicillin Allergy · Penicillin Sensitivity · Penicillin Reaction
Primary: Number of Participants With Confirmed Allergy Status — 28; 6; 6 Participants
University Hospitals Cleveland Medical Center Results Jul 2023 0.0% serious AE View details